Appearance of Focal Nodular Hyperplasia after Chemotherapy in Two Patients during Follow-Up of Colon Carcinoma

Autor: de Wert, L. A., Huisman, S. A., Imani, F., de Gooyer, D. J., van Riel, J. M. G. H., Gobardhan, P. D., Rijken, A. M.

Publikováno v: Case Reports in Surgery.

Surgical liver resection is a treatment option in patients with resectable colorectal liver metastases. We present two cases of focal nodular hyperplasia (FNH) development after treatment with oxaliplatin during follow-up of colon carcinoma. The firs

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=hindawi_publ::cb20ce3b6afb563841e62ae113653032

Identifying the different courses of cognitive functioning across time in patients with breast cancer treated with chemotherapy (abstract)

Autor: Pullens, M. J. J., Vermunt, J. K., Roukema, J. A., Van Riel, J. M. G. H., Roerdink, H. T. J., De Vries, J.

Publikováno v: European Journal of Cancer: Official journal for European Organization for Research and Treatment of Cancer (EORTC), 49, S437-S437. ELSEVIER SCI LTD

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::3a7e41e2a0bf80a25b2fd8c7f60e96e3
https://research.tilburguniversity.edu/en/publications/ef460978-080d-4958-9f56-fd2300a33c46

Angiogenesis- and hypoxia-associated proteins as early indicators of the outcome in patients with metastatic breast cancer given first-line bevacizumab-based therapy

Autor: Lam, Siu W., Nota, Nienke M., Jager, Agnes, Bos, Monique M E M, Van Den Bosch, Joan, Van Der Velden, Ankie M T, Portielje, Johanneke E A, Honkoop, Aafke H., Van Tinteren, Harm, Boven, Epie, De Groot, S. M., Linn, S. C., Braun, H. J., Los, M., Kroep, J. R., Tanis, B., Smorenburg, C. H., Terwogt, J. M Meerum, Van Riel, J. M G H, Den Boer, M. O., Douma, J., Jeurissen, F., Berends, J.

Publikováno v: Lam, S W, Nota, N M, Jager, A, Bos, M M E M, van den Bosch, J, van der Velden, A M T, Portielje, J E A, Honkoop, A H, van Tinteren, H & Boven, E 2016, ' Angiogenesis-and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy ', Clinical Cancer Research, vol. 22, no. 7, pp. 1611-1620 . https://doi.org/10.1158/1078-0432.CCR-15-1005
Clinical Cancer Research, 22(7), 1611-1620. American Association for Cancer Research Inc.
Clinical Cancer Research, 22(7), 1611. American Association for Cancer Research Inc.

Purpose: We examined whether pretreatment levels of angiogenesis- or hypoxia-related proteins and their changes after one cycle of first-line bevacizumab-based therapy were associated with response, PFS, or OS in patients with metastatic breast cance

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbf2727d0d44beb72ff625109285394b
https://doi.org/10.1158/1078-0432.ccr-15-1005

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.